Literature DB >> 8422833

Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy.

M A Crook1, P Tutt, J C Pickup.   

Abstract

OBJECTIVE: In view of the possible link between serum sialic acid and cardiovascular disease in the general population, we investigated whether serum total and lipid-associated sialic concentrations are elevated in NIDDM patients compared with normal subjects. We also investigated how sialic acid levels relate to glycemic control, blood pressure, microalbuminuria, retinopathy, and serum lipid levels. RESEARCH DESIGN AND METHODS: We selected 20 NIDDM patients at random and matched them for age and sex with 20 normal subjects. The patients also had a similar BMI as the control subjects. A first morning blood sample was taken for sialic acid, glucose, fructosamine, and lipid analysis, as was a first morning urine sample for assessment of microalbuminuria. Retinopathy was assessed by fundoscopy.
RESULTS: Both total and lipid-associated sialic acid levels were elevated in the NIDDM patients compared with control subjects (mean +/- SD, total: 0.74 +/- 0.11 vs. 0.60 +/- 0.22 g/L, P < 0.02; lipid-associated: 0.18 +/- 0.04 vs 0.12 +/- 0.04 g/L, P < 0.001). Total serum sialic acid was correlated with systolic blood pressure (r = 0.58, P < 0.01) and diastolic blood pressure (r = 0.58, P < 0.02). There was no significant relationship of total sialic acid with age, duration of diabetes, BMI, microalbuminuria, serum triglyceride, blood glucose, or serum fructosamine. A relationship of lipid-associated sialic acid levels and systolic blood pressure did not reach significance (P = 0.09). In 9 patients with background retinopathy with or without maculopathy, the total serum sialic acid concentration was higher than in those without retinopathy (0.81 +/- 0.09 vs. 0.69 +/- 0.10 g/L, P < 0.008). Lipid-associated sialic acid levels were similar in those with and without retinopathy. (The conversion factor for standard units to SI units is 1 gL = 3.2 mM.)
CONCLUSIONS: Total serum sialic acid levels were significantly elevated in a relatively small group of NIDDM patients and were correlated with hypertension and retinopathy. A larger study of circulating sialic acid concentrations as a risk factor for the development or marker of diabetic angiopathy is therefore justified.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8422833     DOI: 10.2337/diacare.16.1.57

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  18 in total

Review 1.  Endothelial dysfunction, inflammation and diabetes.

Authors:  Paresh Dandona; Ahmad Aljada; Ajay Chaudhuri; Priya Mohanty
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  Insulin Resistance and Markers of Inflammation in HIV-infected Ugandan Children in the CHAPAS-3 Trial.

Authors:  Sahera Dirajlal-Fargo; Victor Musiime; Adrian Cook; Grace Mirembe; Julia Kenny; Ying Jiang; Sara Debanne; Nigel Klein; Grace A McComsey
Journal:  Pediatr Infect Dis J       Date:  2017-08       Impact factor: 2.129

3.  Estimation of salivary and serum total sialic Acid levels in periodontal health and disease.

Authors:  Surekha R Rathod; Farooque Khan; Abhay P Kolte; Madhur Gupta
Journal:  J Clin Diagn Res       Date:  2014-09-20

4.  NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

Authors:  J C Pickup; M B Mattock; G D Chusney; D Burt
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

5.  Glucose supply and insulin demand dynamics of antidiabetic agents.

Authors:  Scott V Monte; Jerome J Schentag; Martin H Adelman; Joseph A Paladino
Journal:  J Diabetes Sci Technol       Date:  2010-03-01

6.  Vanadyl sulfate administration protects the streptozotocin-induced oxidative damage to brain tissue in rats.

Authors:  Refiye Yanardag; Sevim Tunali
Journal:  Mol Cell Biochem       Date:  2006-03-11       Impact factor: 3.396

Review 7.  Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state.

Authors:  Abbas E Kitabchi; Guillermo E Umpierrez; Joseph N Fisher; Mary Beth Murphy; Frankie B Stentz
Journal:  J Clin Endocrinol Metab       Date:  2008-02-12       Impact factor: 5.958

8.  Effects of Diaceto-Dipropyl-Disulphide on Plasma Sialic Acid and Renal Tissue Thiol Levels in Alloxan Diabetic Rats.

Authors:  Vijay Venkataiah; Kashinath Rattihalli Thirumalarao; Veena Gajana Raiker; Sandhya Hanumanthappa Puttaswamy
Journal:  J Clin Diagn Res       Date:  2016-06-01

9.  The correlation between blood oxidative stress and sialic acid content in diabetic patients with nephropathy, hypertension, and hyperlipidemia.

Authors:  Sedigheh Shahvali; Armita Shahesmaeili; Mojgan Sanjari; Somayyeh Karami-Mohajeri
Journal:  Diabetol Int       Date:  2019-05-09

10.  Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS).

Authors:  S S Soedamah-Muthu; N Chaturvedi; J C Pickup; J H Fuller
Journal:  Diabetologia       Date:  2008-01-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.